Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of an Incontinence Product

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* English speaking/reading adults, age ≥ 18 years~* Incontinent (fecal, urine, or dual incontinence)~* Patients with dual incontinence who require use of a fecal management system (but no urinary catheter)~* Absence of skin irritation, breakdown, and pressure injuries present in the buttocks, sacrum, and/or perineal areas at the time of enrollment; minor irritation may be acceptable at the discretion of the Study Investigator~* Willing and able to provide written informed consent or legal authorized representative is willing and able to provide written informed consent~Exclusion Criteria:~* Presence of skin irritation and/or breakdown including but not limited to IAD or pressure injuries present in the buttocks, sacrum, and/or perineal areas at the time of enrollment; minor irritation may be acceptable at the discretion of the study Investigator~* Require use of an absorbent undergarment (e.g. Depends) or catheter as the primary incontinence management strategy~* Is considered to be near death or requires hospice care

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Phase 1 (Type: None): Subjects will use the incontinence pad with incontinence detection notifications turned on
- Phase 2 (Type: None): Subjects will use the incontinence pad with incontinence notification turned off

Based on this trial design, predict the completion outcome and termination type (if applicable).